These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26739079)

  • 1. [Signal intensity-time curve and quantitative dynamic contrast-enhanced magnetic resonance imaging in differentiating neoplasms of uterus].
    Guo Y; Jiang X; Liu G; Huang Y; Xu X
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2015 Dec; 40(12):1357-64. PubMed ID: 26739079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiation of Benign from Malignant Adnexal Masses by Dynamic Contrast-Enhanced MRI (DCE-MRI): Quantitative and Semi-quantitative analysis at 3-Tesla MRI.
    Gity M; Parviz S; Saligheh Rad H; Fathi Kazerooni A; Shirali E; Shakiba M; Baikpour M
    Asian Pac J Cancer Prev; 2019 Apr; 20(4):1073-1079. PubMed ID: 31030476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Feasibility study of dynamic contrast enhanced magnetic resonance imaging qualitative diagnosis of musculoskeletal tumors].
    Zhang J; Zuo PL; Cheng KB; Yu AH; Cheng XG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2016 Apr; 48(2):287-91. PubMed ID: 27080283
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Benign or Malignant Characterization of Soft-Tissue Tumors by Using Semiquantitative and Quantitative Parameters of Dynamic Contrast-Enhanced Magnetic Resonance Imaging.
    Zhang Y; Yue B; Zhao X; Chen H; Sun L; Zhang X; Hao D
    Can Assoc Radiol J; 2020 Feb; 71(1):92-99. PubMed ID: 32062994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of optimized magnetic resonance perfusion imaging scanning time window after contrast agent injection for differentiating benign and malignant breast lesions.
    Dong J; Wang D; Ma Z; Deng G; Wang L; Zhang J
    Exp Ther Med; 2017 Mar; 13(3):1069-1073. PubMed ID: 28450944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The value of dynamic contrast-enhanced MRI in the differentiation between benign and malignant lacrimal epithelial tumors].
    Wang YZ; Xian JF; Wang XY; Guo J; Song LY
    Zhonghua Yi Xue Za Zhi; 2023 Aug; 103(31):2427-2432. PubMed ID: 37599217
    [No Abstract]   [Full Text] [Related]  

  • 7. Combined diffusion-weighted imaging and dynamic contrast-enhanced MRI for differentiating radiologically indeterminate malignant from benign orbital masses.
    Xu XQ; Qian W; Ma G; Hu H; Su GY; Liu H; Shi HB; Wu FY
    Clin Radiol; 2017 Oct; 72(10):903.e9-903.e15. PubMed ID: 28501096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differentiation of grade II and III oligodendrogliomas from grade II and III astrocytomas: a histogram analysis of perfusion parameters derived from dynamic contrast-enhanced (DCE) and dynamic susceptibility contrast (DSC) MRI.
    Lee JY; Ahn KJ; Lee YS; Jang JH; Jung SL; Kim BS
    Acta Radiol; 2018 Jun; 59(6):723-731. PubMed ID: 28862024
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative dynamic contrast-enhanced MR imaging for differentiating benign, borderline, and malignant ovarian tumors.
    Li HM; Feng F; Qiang JW; Zhang GF; Zhao SH; Ma FH; Li YA; Gu WY
    Abdom Radiol (NY); 2018 Nov; 43(11):3132-3141. PubMed ID: 29556691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Significance of DCE-MRI-Related Quantitative Parameters for Nasal Cavity and Sinus Tumors.
    Zhang H; Li LY; Yu LY; Liu NB; Yang D; Zhang SJ; Xu JH
    Altern Ther Health Med; 2023 Nov; ():. PubMed ID: 37971454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical value of DCE-MRI for differentiating secondary laryngeal cartilage lesions.
    Yu J; Xu W; Wang L; Jiang N; Dou W; Li C; Sun L
    Medicine (Baltimore); 2023 Mar; 102(13):e33352. PubMed ID: 37000106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitative analysis of 3-Tesla magnetic resonance imaging in the differential diagnosis of breast lesions.
    Ma ZS; Wang DW; Sun XB; Shi H; Pang T; Dong GQ; Zhang CQ
    Exp Ther Med; 2015 Mar; 9(3):913-918. PubMed ID: 25667653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual-input two-compartment pharmacokinetic model of dynamic contrast-enhanced magnetic resonance imaging in hepatocellular carcinoma.
    Yang JF; Zhao ZH; Zhang Y; Zhao L; Yang LM; Zhang MM; Wang BY; Wang T; Lu BC
    World J Gastroenterol; 2016 Apr; 22(13):3652-62. PubMed ID: 27053857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application on the quantitative perfusion parameters of dynamic contrast-enhanced MRI in the pathological subtype of uterine leiomyoma].
    Zheng J; Zhao ZH; Yang JF; Zhao L; Yang LM; Hu HJ
    Zhonghua Yi Xue Za Zhi; 2017 Apr; 97(15):1155-1159. PubMed ID: 28427122
    [No Abstract]   [Full Text] [Related]  

  • 15. High-Resolution Diffusion-Weighted Imaging Improves the Diagnostic Accuracy of Dynamic Contrast-Enhanced Sinonasal Magnetic Resonance Imaging.
    Wang F; Sha Y; Zhao M; Wan H; Zhang F; Cheng Y; Tang W
    J Comput Assist Tomogr; 2017; 41(2):199-205. PubMed ID: 27560026
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Diffusion weighted imaging and perfusion weighted imaging in the differential diagnosis of benign and malignant renal masses on 3.0 T MRI].
    Xu X; Wang P; Ma L; Shao Z; Zhang M
    Zhonghua Yi Xue Za Zhi; 2015 Jan; 95(3):200-4. PubMed ID: 25877031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of quantitative and semi-quantitative parameters of DCE-MRI in differential diagnosis of benign and malignant cervical tumors.
    Song J; Gu Y; Du T; Liu Q
    Am J Transl Res; 2021; 13(11):12228-12234. PubMed ID: 34956449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discrimination between benign and malignant lung lesions using volumetric quantitative dynamic contrast-enhanced MRI.
    Wei F; Weidong F; Wenming Z; Lei H; Xiaosan C; Zhongliang M; Qianyun L; Huashan L
    Curr Med Imaging; 2023 Jul; ():. PubMed ID: 37497704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnostic value of quantitative pharmacokinetic parameters and relative quantitative pharmacokinetic parameters in breast lesions with dynamic contrast-enhanced MRI].
    Sun TT; Liu WH; Zhang YQ; Li LH; Wang R; Ye YY
    Zhonghua Yi Xue Za Zhi; 2017 Aug; 97(29):2266-2270. PubMed ID: 28780840
    [No Abstract]   [Full Text] [Related]  

  • 20. Orbital benign and malignant lymphoproliferative disorders: Differentiation using semi-quantitative and quantitative analysis of dynamic contrast-enhanced magnetic resonance imaging.
    Hu H; Xu XQ; Liu H; Hong XN; Shi HB; Wu FY
    Eur J Radiol; 2017 Mar; 88():88-94. PubMed ID: 28189215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.